Younes Belkouchi

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Resistance Training

Magnetic Resonance

Positron Emission Tomography

Childhood Cancer

Top Venues

Diagnostics (Basel, Switzerland)

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Pierre Decazes, Samy Ammari, Antoine De Prévia, Léo Mottay, Littisha Lawrance, Younes Belkouchi, Baya Benatsou, Laurence Albiges, Corinne Balleyguier, Pierre Vera, Nathalie Lassau
Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs. Diagnostics (Basel, Switzerland) 13 (2) (2023)
Pierre Decazes, Samy Ammari, Antoine De Prévia, Léo Mottay, Littisha Lawrance, Younes Belkouchi, Baya Benatsou, Laurence Albiges, Corinne Balleyguier, Pierre Vera, Nathalie Lassau
Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs. Diagnostics (Basel, Switzerland) 13 (2) (2023)
Pierre Decazes, Samy Ammari, Antoine De Prévia, Léo Mottay, Littisha Lawrance, Younes Belkouchi, Baya Benatsou, Laurence Albiges, Corinne Balleyguier, Pierre Vera, Nathalie Lassau
Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs. Diagnostics (Basel, Switzerland) 13 (2) (2023)
Younes Belkouchi, Hugues Talbot, Nathalie Lassau, Littisha Lawrance, Siham Farhane, Rahma Feki-Mkaouar, Joya Hadchiti, Lama Dawi, Julien Vibert, Paul-Henry Cournede, Clara Cousteix, Camille Mazza, Michèle Kind, Antoine Italiano, Aurélien Marabelle, Samy Ammari, Stephane Champiat
Better than RECIST and faster than iRECIST: defining the Immunotherapy Progression Decision score to better manage progressive tumors on immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Raphael Naccache, Younes Belkouchi, Littisha Lawrance, Baya Benatsou, Joya Hadchiti, Paul-Henry Cournede, Samy Ammari, Hugues Talbot, Nathalie Lassau
Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker. Cancers 14 (5) (2022)